COVID has forced the pharma industry to step up and take a more innovative approach to the channels and content it uses to reach and engage with HCPs, says Chloe Prince, account director at
The amount of patient data has skyrocketed, providing opportunities to gain a deeper understanding of diseases that are particularly complex or areas with a high level of unmet need, accord
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
